↓ Skip to main content

Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, April 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
44 Mendeley
Title
Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
Published in
European Journal of Clinical Microbiology & Infectious Diseases, April 2019
DOI 10.1007/s10096-019-03503-4
Pubmed ID
Authors

Carlos Rubio-Terrés, José María Aguado, Benito Almirante, Javier Cobo, Santiago Grau, Miguel Salavert, Elena González Antona Sánchez, Cristina López Gutiérrez, Darío Rubio-Rodríguez

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 9%
Student > Master 3 7%
Researcher 3 7%
Student > Ph. D. Student 3 7%
Student > Doctoral Student 2 5%
Other 6 14%
Unknown 23 52%
Readers by discipline Count As %
Medicine and Dentistry 9 20%
Business, Management and Accounting 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Economics, Econometrics and Finance 2 5%
Nursing and Health Professions 1 2%
Other 2 5%
Unknown 25 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2022.
All research outputs
#15,208,410
of 23,381,576 outputs
Outputs from European Journal of Clinical Microbiology & Infectious Diseases
#1,829
of 2,818 outputs
Outputs of similar age
#209,487
of 353,735 outputs
Outputs of similar age from European Journal of Clinical Microbiology & Infectious Diseases
#21
of 52 outputs
Altmetric has tracked 23,381,576 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,818 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,735 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.